Cannabis Law Report

JANUARY 14, 2022

Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.

Treatment 52

Treatment Access Clinical Trials Patients 52

The Cannigma

APRIL 12, 2023

Sleep is not often the focus of clinical trials on cannabis; rather it is often a secondary outcome. This direct access to consumers allows MoreBetter to conduct informal studies, collecting data from a set of participants with a selected product over a set amount of time. Has CBN been proven to help with sleep?

Sleep 137

Sleep Data Tincture Research and Development 137

Cannabis Law Report

AUGUST 12, 2021

11, 2021 (GLOBE NEWSWIRE) COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the second quarter 2021 and gave an update on recent progress across its business. LONDON, Aug. Business highlights.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

MMJ Recs

JULY 9, 2024

Medical Marijuana: An Overview Medical marijuana refers to the use of cannabis and its cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), for medicinal purposes. Some clinical trials have shown that cannabinoids, particularly THC and CBD, effectively reduce muscle spasticity and pain in MS patients.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. A Push by Patients. Patients Are Not In This Alone.

Therapy 64

Therapy DEA Patients Clinical Trials 64

Cannabis Law Report

JANUARY 21, 2020

Below are the numbers of approvals for unapproved products during 2019 via Category B of the Special Access Scheme (SAS). The figures do not include patients accessing medicinal cannabis outside the SAS via the Authorised Prescriber scheme or a clinical trial. January – 670. February – 738. March – 1043. April – 1108.

Access 45

Access Patients Clinical Trials Medicine 45

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. References Staff, T. 2019) Cannabis may help relieve Autism symptoms, Israeli study shows.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

The Cannigma

MAY 17, 2022

Indica and sativa are plant names that refer to the physical differences between the plant, not the chemical compound within the nugs. 15 Multiple clinical trials have shown that linalool in ylang ylang oil and lavender oil “significantly increased calmness.” src="[link] frameborder="0" allowfullscreen="">.

Terpenes 133

Terpenes Strains THC Oil 133

Cannabis Law Report

JULY 28, 2021

MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. Performs regulatory document formatting in Word utilizing styles, captions, cross-references/hyperlinking, and citation management. Experience working for a clinical study Sponsor.

Clinical Trials 81

Clinical Trials Research and Development Data Environment 81

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. PRESS RELEASE. ” About COMPASS Pathways.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Canna Care Docs

DECEMBER 11, 2018

Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. References. Accessed December 5 2018. Accessed December 5 2018. But what explains this turnaround, and what do seniors need to be aware of when it comes to medical cannabis? Geoffrey W.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

JANUARY 26, 2022

MAPS Public Benefit Corporation will coordinate trial design with Medicines and Healthcare products Regulatory Agency to create a road map for early patient access in the UK. No drug is without risks, so clinical trials have included careful investigation of possible adverse effects.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

The Cannigma

MAY 6, 2021

3 It has less of an affinity to endocannabinoid receptors, however, which is likely why it causes more moderate effects — and why delta-8 is often referred to as “weed light.” If you have access to regulated cannabis that’s produced under acceptable standards, there’s no real reason to seek delta-8 products. Delta-8-THC research.

THC 145

THC Cannabinoids Concentrates Hemp 145

The Cannigma

JULY 1, 2022

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development 124

Research and Development Data THC Clinical Trials 124

Cannabis Law Report

DECEMBER 14, 2019

Now, unless the patient is under 16 years old or has a history of drug abuse, medical practitioners in New South Wales can prescribe cannabis medicines without having to refer to a specialist. There’s also been a decrease in pricing pressure for medical cannabis patients throughout the country.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Miss Marijuana

FEBRUARY 7, 2025

CBD , on the other hand, is generally more accessible. While more clinical trials are needed, THC has already been shown to help improve quality of life for those dealing with these conditions. This synergy is often referred to as the “entourage effect,” where the two cannabinoids work together to enhance each other’s benefits.

THC 52

THC CBD Chronic Pain Cannabinoids 52

MMJ Recs

JULY 17, 2024

Medical marijuana refers to the use of cannabis and its cannabinoids to treat medical conditions, including the side effects of chemotherapy. Clinical trials have highlighted the efficacy of medical marijuana in managing pain, suggesting it as a potential alternative or adjunct to traditional pain medications.

Marijuana 52

Marijuana Treatment Patients Therapy 52

MMJ Recs

JULY 11, 2024

Medical marijuana refers to the use of cannabis and cannabinoids for medical purposes, such as using cannabis for insomnia relief, to alleviate symptoms, or to treat conditions under medical supervision. Another option available is the use of medical marijuana to address insomnia in patients.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. References Staff, T. 2019) Cannabis may help relieve Autism symptoms, Israeli study shows.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

OCTOBER 5, 2021

Terms of Reference. The review excludes pre-clinical trials (i.e. Given our increasing mental health emergency, equitable access to these treatments has never been more important. The Delegate’s final decision is anticipated to be published the first week of December 2021. We could not have done it without you.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

MMJ Recs

JULY 3, 2024

Stress, on the other hand, refers to the body’s response to external pressures or demands. This variability can pose challenges for medical marijuana patients seeking consistent access to safe and effective CBD products, as well as for businesses aiming to comply with a patchwork of state laws. Image by Suzy Hazelwood on Pexels.

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

MMJ Recs

AUGUST 1, 2024

As the legal landscape evolves, increasing numbers of patients can access medical marijuana, leading to more research and better regulation. Medical marijuana, through its appetite-stimulating effects (often referred to as “the munchies”), can combat this condition.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases. The trial is currently registered with the Australian New Zealand Clinical Trials Registry (ANZCTR).

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Therapy 40

Cannabis Law Report

OCTOBER 3, 2019

The Terms of Reference of the review required Professor McMillan AO to make recommendations on the efficiency and effectiveness of the regime with consideration of the regulatory burden on stakeholders. We provide an overview of the key findings and recommendations of the Final Report below. Key findings.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. REFERENCE to the EU acquis. Draft Law of Ukraine. ARV (revised). explanatory note. Comparative table.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

DECEMBER 7, 2021

Since 2017, several clinical trials and observational studies have examined the efficacy of MCs in the pediatric population for a few indications, most of them focused on CBD efficacy in Dravet syndrome 28 , 29 , 30. For eligible publications with missing data, the corresponding author was contacted to access additional data.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

JUNE 11, 2019

Despite the recent legalization of cannabis, a framework for access to cannabis for medical purposes still exists, but under new regulations passed under the authority of the Cannabis Act. Prior to that, cannabis was regulated under the Controlled Drugs and Substances Act. In rejecting the claim, the court cited Torchia v.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Canna Law Blog

NOVEMBER 10, 2020

We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. It’s quite restrictive. Or, it could be because FDA is sort of a drag about everything.

Therapy 98

Therapy Clinical Trials Decriminalization Treatment 98

Veriheal

DECEMBER 21, 2022

Decriminalization refers to the relaxation of criminal penalties associated with personal cannabis use. While both options seem better than the current situation, they could actually make it more difficult to access. Descheduling Cannabis. This bright-eyed hope for federal cannabis reform is closer than it has ever been.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

The Cannigma

DECEMBER 12, 2022

Many psychedelics are also referred to as entheogens, which are substances that expand consciousness for religious or spiritual purposes. Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving.

History 141

History Microdosing Research and Development Clinical Trials 141

MMJ Recs

APRIL 1, 2024

Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders. While CBD can be derived from both hemp and marijuana plants, medical marijuana typically refers to cannabis strains containing higher levels of THC.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Veriheal

JULY 12, 2021

For veterans, PTSD (sometimes referred to as ‘shell shock’ or ‘combat stress’) can severely impact their livelihood. While more certainty is required in the form of clinical trials, plenty of anecdotal reports concerning cannabis for PTSD display the potential benefits one can get from medical cannabis.

Treatment 105

Treatment Sleep Clinical Trials Data 105

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Greencamp

AUGUST 16, 2018

The first study I will reference is from 2006, conducted on mice. Our body produces internal cannabinoids called endocannabinoids, and the compounds from the cannabis plant access the ECS in a similar manner as our own endocannabinoids. References.

Strains 94

Strains Cannabinoids Research and Development Indica 94